Weiss Multi-Strategy Advisers LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$34
-29.2%
48,894
-9.5%
0.00%0.0%
Q1 2023$48
-37.7%
54,054
-16.8%
0.00%
-50.0%
Q4 2022$77
-100.0%
65,000
-35.0%
0.00%
-90.0%
Q3 2022$753,000
-15.1%
100,000
-29.0%
0.02%
-25.9%
Q2 2022$887,000
-31.1%
140,749
-9.2%
0.03%
-10.0%
Q1 2022$1,287,000
+18.4%
155,000
-26.0%
0.03%
+20.0%
Q4 2021$1,087,000
-23.6%
209,428
-1.7%
0.02%
-19.4%
Q3 2021$1,423,000
-19.3%
213,000
+2.9%
0.03%
-20.5%
Q2 2021$1,764,000
-0.3%
207,000
+3.5%
0.04%0.0%
Q1 2021$1,770,000
-27.1%
200,000
+1.2%
0.04%
-17.0%
Q4 2020$2,428,000
+55.3%
197,547
+2.9%
0.05%
+11.9%
Q3 2020$1,563,000
-12.0%
192,000
+3.8%
0.04%
-17.6%
Q2 2020$1,776,000
+67.4%
185,000
+18.6%
0.05%
+24.4%
Q1 2020$1,061,000
-52.5%
156,000
+4.0%
0.04%
+10.8%
Q4 2019$2,235,000
+55.7%
150,000
+7.1%
0.04%
+27.6%
Q3 2019$1,435,000
+4.1%
140,000
+7.7%
0.03%
-19.4%
Q2 2019$1,378,000
-6.1%
130,000
+23.8%
0.04%
-2.7%
Q1 2019$1,468,000
+37.6%
105,0000.0%0.04%
-15.9%
Q4 2018$1,067,000
+154.0%
105,000
+200.0%
0.04%
+300.0%
Q3 2018$420,00035,0000.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders